- Conditions
- Asthma
- Interventions
- NC100182 Hyperpolarized 3He
- Other
- Lead sponsor
- University of Wisconsin, Madison
- Other
- Eligibility
- 6 Years and older
- Enrollment
- 107 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2012 – 2021
- U.S. locations
- 1
- States / cities
- Madison, Wisconsin
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1489–1512
of 1,696
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Asthma (Diagnosis)
- Interventions
- Sensor-Enabled mHealth Intervention for Adolescents with Suboptimal Asthma Control, mHealth standard of care control condition
- Behavioral
- Lead sponsor
- University of Kansas
- Other
- Eligibility
- 13 Years to 17 Years
- Enrollment
- 160 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2028
- U.S. locations
- 2
- States / cities
- Jacksonville, Florida • Lawrence, Kansas
- Conditions
- Children, Asthma
- Interventions
- Not listed
- Lead sponsor
- Boston Children's Hospital
- Other
- Eligibility
- 2 Years and older
- Enrollment
- 273 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2016
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Asthma; Status, Asthma in Children, Asthma Acute, Asthma Attack, Acute Asthma Exacerbation
- Interventions
- Montelukast Oral Granules
- Drug
- Lead sponsor
- Vanderbilt University Medical Center
- Other
- Eligibility
- 5 Years to 17 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2029
- U.S. locations
- 1
- States / cities
- Nashville, Tennessee
- Conditions
- Asthma
- Interventions
- Placebo MDPI, Albuterol MDPI
- Drug
- Lead sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 158 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2013
- U.S. locations
- 38
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Costa Mesa, California + 30 more
- Conditions
- Asthma, Perennial Allergic Rhinitis
- Interventions
- Mouse Allergenic Extract
- Biological
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2016
- U.S. locations
- 4
- States / cities
- Washington D.C., District of Columbia • Chicago, Illinois • Baltimore, Maryland + 1 more
- Conditions
- Asthma
- Interventions
- Montelukast, Singulair
- Drug
- Lead sponsor
- Roxane Laboratories
- Industry
- Eligibility
- 18 Years to 45 Years
- Enrollment
- 35 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008
- U.S. locations
- 1
- States / cities
- Fargo, North Dakota
- Conditions
- Asthma, Obesity
- Interventions
- Remote digital therapeutic exercise program
- Other
- Lead sponsor
- University of Vermont
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2025
- U.S. locations
- 1
- States / cities
- Burlington, Vermont
- Conditions
- Asthma
- Interventions
- Placebo, FP 100mcg, FP 500mcg, FP 250mcg, FSC 100/50mcg, FSC 250/50mcg, FSC 500/50mcg
- Drug
- Lead sponsor
- GlaxoSmithKline
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 464 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2004
- U.S. locations
- 52
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 45 more
- Conditions
- Asthma
- Interventions
- Asthma education for parents of very low birth weight infants
- Behavioral
- Lead sponsor
- University of Rochester
- Other
- Eligibility
- 30 Days to 1 Year
- Enrollment
- 192 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2006
- U.S. locations
- 1
- States / cities
- Rochester, New York
- Conditions
- Asthma
- Interventions
- Fenzian Device, Sham Device
- Device
- Lead sponsor
- University of California, Los Angeles
- Other
- Eligibility
- 12 Years to 80 Years
- Enrollment
- 81 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2011
- U.S. locations
- 3
- States / cities
- Los Angeles, California • Baltimore, Maryland • Durham, North Carolina
- Conditions
- Asthma, Children, Physical Activity
- Interventions
- asthma physical activity intervention
- Behavioral
- Lead sponsor
- Montefiore Medical Center
- Other
- Eligibility
- 7 Years to 12 Years
- Enrollment
- 208 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2014
- U.S. locations
- 1
- States / cities
- The Bronx, New York
- Conditions
- Asthma
- Interventions
- TEV-48574, Placebo
- Drug
- Lead sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 65 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2022
- U.S. locations
- 55
- States / cities
- Birmingham, Alabama • Little Rock, Arkansas • Bakersfield, California + 47 more
- Conditions
- Asthma
- Interventions
- Zileuton CR, Placebo
- Drug
- Lead sponsor
- Critical Therapeutics
- Industry
- Eligibility
- 12 Years to 70 Years
- Enrollment
- 400 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 1
- States / cities
- Lexington, Massachusetts
- Conditions
- Exercise-induced Bronchospasm
- Interventions
- arformoterol, formoterol, placebo
- Drug
- Lead sponsor
- University of New Mexico
- Other
- Eligibility
- 12 Years to 17 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 1
- States / cities
- Albuquerque, New Mexico
- Conditions
- Asthma
- Interventions
- dupilumab, Matching placebo
- Drug
- Lead sponsor
- Regeneron Pharmaceuticals
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2023
- U.S. locations
- 13
- States / cities
- Rolling Hills Estates, California • Torrance, California • Westminster, California + 10 more
- Conditions
- Asthma
- Interventions
- Placebo Spiromax, Albuterol Spiromax
- Drug
- Lead sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 331 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010
- U.S. locations
- 30
- States / cities
- Scottsdale, Arizona • Los Angeles, California • San Diego, California + 27 more
- Conditions
- Asthma, Lung Diseases
- Interventions
- Facilitated Asthma Communication Intervention (FACI), Breathmobile intervention
- Behavioral
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- 2 Years to 6 Years
- Enrollment
- 336 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2009
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- Asthma
- Interventions
- Lebrikizumab, Placebo
- Drug
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 1,068 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2017
- U.S. locations
- 66
- States / cities
- Birmingham, Alabama • Scottsdale, Arizona • Tucson, Arizona + 54 more
- Conditions
- Bronchiolitis
- Interventions
- Dexamethasone Oral
- Drug
- Lead sponsor
- IDeA States Pediatric Clinical Trials Network
- Network
- Eligibility
- 0 Months to 24 Months
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2025
- U.S. locations
- 2
- States / cities
- Little Rock, Arkansas • Omaha, Nebraska
- Conditions
- Asthma
- Interventions
- Paper Asthma Action Plan, Mobile Phone
- Other · Device
- Lead sponsor
- Arkansas Children's Hospital Research Institute
- Other
- Eligibility
- 12 Years to 17 Years
- Enrollment
- 34 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014 – 2015
- U.S. locations
- 1
- States / cities
- Little Rock, Arkansas
- Conditions
- Asthma
- Interventions
- Fluticasone propionate/salmeterol, Advair Diskus, 100 Mcg-50 Mcg Inhalation Powder, Placebo
- Drug
- Lead sponsor
- West-Ward Pharmaceutical
- Industry
- Eligibility
- 12 Years to 65 Years
- Enrollment
- 1,556 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2019
- U.S. locations
- 1
- States / cities
- Las Vegas, Nevada
- Conditions
- Asthma
- Interventions
- Exhaled nitric oxide (eNO)
- Device
- Lead sponsor
- Apieron
- Industry
- Eligibility
- 5 Years and older
- Enrollment
- 150 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007
- U.S. locations
- 2
- States / cities
- Shreveport, Louisiana • Lake Oswego, Oregon
- Conditions
- Asthma, Allergic, Asthma, Obesity
- Interventions
- Not listed
- Lead sponsor
- Duke University
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 28 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2025
- U.S. locations
- 1
- States / cities
- Durham, North Carolina